My Authors
Read all threads
Better headline: Drug company juices stock price by pre-releasing details of a coronavirus study lacking a control group that showed no difference between people on remdesivir for 5 days versus 10 days...
The Lancet has released a controlled study showing that the antiviral remdesivir did not show benefit in a trial of severe coronavirus patients. This appears to be the study accidentally leaked last week in a WHO database...
Note: The Lancet released this study ::checks notes:: 7 hours ahead of its original embargo time.

The journal shared its intention to publish this morning, 30 minutes before Gilead's statement on the uncontrolled trial mentioned at the top of this thread
Missing some Tweet in this thread? You can try to force a refresh.

Enjoying this thread?

Keep Current with Nsikan Akpan

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!